Company Profile
  News
Boehringer IngelheimBoehringer Ingelheim Our UK News
Boehringer IngelheimBoehringer Ingelheim Our Global News
Boehringer IngelheimBoehringer Ingelheim Our News for Medical Journalists
Boehringer IngelheimBoehringer Ingelheim News Archive
Boehringer IngelheimBoehringer Ingelheim Health News
Boehringer IngelheimBoehringer Ingelheim Health News Archive
Boehringer IngelheimBoehringer Ingelheim Eloquium Award
  Conditions
  Medicines
  Community Spirit
  Careers
Boehringer Ingelheim
Boehringer Ingelheim UK
Health news

News

Study: Cardiac arrhythmias get a new insight

Friday, May 09, 2008

A novel insight into the molecular mechanisms that cause arrhythmia, or irregular heartbeat, which can lead to sudden death, has been achieved by researchers at Rhode Island Hospital.

The findings of the study could be used to develop genetically-targeted therapies to treat and prevent potentially fatal arrhythmias.

One of the conditions that can cause sudden death is the long QT syndrome (LQTS), a disorder that results in fast, chaotic heartbeats. An LQTS is linked to an increased likelihood of life-threatening arrhythmia.

Dr Gideon Koren, director of the cardiovascular research centre at Rhode Island Hospital and a Professor of medicine at the Warren Alpert Medical School of Brown University, said that scientists are still struggling to explain why arrhythmia causes sudden cardiac death in some patients, but not others.

"One of the reasons we know so little about it is that, until now, there has not been a good animal model for study," he added.

So, he and his team developed an animal model of LQTS - the first to mimic what happens during arrhythmia in humans - in order to study the various mechanisms that trigger the condition and cause sudden death.

This is the first step towards a better understanding of the issue, but there is much more that scientists still do not know, concluded Dr Koren.

Heart disease was the number one cause of death in the United States in 2005, with 652,091 people dying from the condition, according to figures from the National Centre for Health Statistics.


ADNFCR-449-ID-18586275-ADNFCR© Adfero Ltd

Other News



Boehringer Ingelheim
Corporate Site


10 May 2008
  Contact us
  How to find us
  Search
  Site map
Boehringer Ingelheim Voted Great Place to Work for Fourth Year Running
 
Boehringer Ingelheim Websites
Boehringer Ingelheim
Large Text
 

Boehringer Ingelheim UK websites:
Corporate: Boehringer Ingelheim UK, Boehringer Ingelheim Corporate Site
Consumer Health Care: Pharmaton, Antistax, Dulcolax, Healthy Legs, IBS Relief, Constipation facts, Pass it On, Dulcoease, 1in4men
Animal Health: Vetmedin, Metacam, Ingelvac Myho, Mamyzin, Seraquin
Access to and use of this website is subject to our Terms of use which users are deemed to accept by accessing this website.
© 2008 Boehringer Ingelheim Ltd UK. All rights reserved. Company Registration Number: 711858 England & Wales
Boehringer Ingelheim Limited, Registered Office, Ellesfield Avenue, Bracknell, Berks RG12 8YS